One of the biggest cannabis U.S. operators publicly trading in a Canadian exchange provided shareholders with an update on their sales for the month of March in the state of Arizona.

On Tuesday (April 3) MPX Bioceutical Corporation (CSE:MPX; OTC:MPXEF) issued a statement revealing to investors the company reached a benchmark of US$4 million, representing roughly C$5.2 million in sales for the month of March alone.


Beth Stavola, COO, and president of MPX’s U.S. operations said in the statement that Arizona is a great state for the company. She added the company is satisfied with the regulations from the Arizona Department of Health Services (AZDHS).

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

“The Arizona program is well-regulated by AZDHS, the patient count continues to grow, the supply and cost of flower and trim for re-sale and concentrate production is excellent and, while the Phoenix area market is increasingly competitive, retail prices and margins remain attractive,” Stavola said.

MPX holds a variety of assets in the U.S. market, but this year the company announced an expansion in Arizona by acquiring the assets of the membership units of ABACA, Ambary, Tarmac Manufacturing, and Tower Management Holdings.

The company reported sales progression after expanding its footprint in Arizona

During a recent update call with analysts and investors from MPX, Stavola revealed the company’s market share in Arizona amounted to roughly seven or eight percent.

After revealing its expansion in Arizona chairman, president, and CEO of MPX Scott Boyes said the new acquisitions had “recorded trailing 12-month revenues of US$15 million and EBITDA of approximately US$3.5 million.”

Instead of waiting for the pursuit of an LP status, Boyes told the Investing News Network (INN) last year MPX would instead invest in legal cannabis states in the U.S. market.

The company now holds three operating dispensaries, two cultivation and two concentrate production facilities in the Greater Phoenix area.

Investor takeaway

Canaccord Genuity began its official coverage of MPX this year. In March analyst Matt Bottomley issued his first full-length report on the company’s development, starting his coverage with a “Speculative Buy” rating and a price target of C$1.15.

“We believe investing in vertically integrated operations is of particular importance, as owning retail distribution channels both increases operating margins and protects against wholesale pricing pressures and cultivation commoditization,” Bottomley wrote.

“We believe successful branding strategies and retail distribution will eventually determine industry winners,” he added.

In his research, the analyst noted MPX’s value comes from already owning branded dispensaries, holding award-winning brands and leading the medical market in Arizona.

According to Bottomley, the speculative rating was given due to the MPX’s high growth profile and the continued lack of US federal support.

After the markets closed on Tuesday, MPX’s share price was valued at C$0.70, representing no percentage change from Monday’s trading period.

So far in, 2018 the company’s stock on the Canadian Securities Exchange (CSE) has tumbled 37.50 percent, representing a C$0.42 loss.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) announces it has completed a first closing of a non-brokered private placement of up to $2,000,000. The Company accepted subscriptions for 13,740,000 units at a price of $0.05 per unit, for gross proceeds of $687,000. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share at $0.075 for a period of two years from the date of closing, subject to the option of the Company to accelerate the expiry date in the event that its shares trade at $0.15 or more for 10 consecutive days

The Company paid $18,000 in cash and issued 160,000 warrants on the same terms as noted above to qualified finders. Securities issued pursuant to this tranche are subject to trading restrictions until April 5, 2021. The Company is expecting to complete the financing by December 16, 2020. Proceeds will be used for working capital and to fund future investments.

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”), announces that further to its press release dated December 3, 2020, the TSX Venture Exchange has approved the repricing of 19,405,804 warrants of the Company that were originally issued on July 27, 2018, to $0.10. These warrants are set to expire on December 31, 2020.

For anybody wishing to exercise these Warrants, please contact the Chief Executive Officer, Terry Donnelly at the particulars below.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN), Aurora Cannabis (NYSE: ACB) (TSX: ACB), and HEXO Corp. (NYSE: HEXO)

Cannabis leaders are focusing on innovation in premium branding, global expansion, and tight operational execution in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders:

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has closed the 2nd and final tranche of its Unit financing. In connection with the closing, the Company issued 1,356,873 Units at a price of $0.55 per Unit, for gross proceeds of $746,280.15. Each Unit consists of one (1) common share and one (1) warrant. Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $0.75 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE (or such other stock exchange the Company’s shares may be trading on) is equal to or greater than $1.25 for a period of 20 consecutive trading days. Finder’s fees of $42,542, 3,200 Finder’s shares and 80,550 Finder’s warrants were issued in connection with finder’s fees payable.

In total, the Company raised gross proceeds of $1,757,180 and issued 3,194,873 Units.

Keep reading... Show less

 Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) (“Sweet Earth” the “Company”) is pleased to announce that it has received full Depository Trust Company (“DTC”) eligibility in the United States. On October 20, 2020, Sweet Earth announced that its shares had been listed on the United States’ Over-The-Counter Bulletin (“OTCQB”) under the ticker SEHCF.

DTC status means that Sweet Earth shares are now eligible to be transferred between brokerage accounts within the United States and significantly augments the ease in which American-based investors are able to trade Sweet Earth shares.

Keep reading... Show less